The long-lasting phase when alternative selectivity is required
Jul 28 2010
Eternity PhenylHexyl is our latest product for separation and purification of compounds for reversed phase HPLC and UHPLC. The product is based on a patent pending grafting technology, the Eternity platform, which was recently introduced as the Eternity C18 phase. Starting from the Eternity platform it is functionalized with a mono-functional PhenylHexyl group followed by a proprietary end-capping process.
The Eternity PhenylHexyl phase provides you with an alternative selectivity compared to a traditional alkyl chain phase or a polar embedded phase, especially when the analytes of interest contain an aromatic ring. Including excellent peak shapes for compounds under both low and high pH conditions (stable between pH 2 to pH 12) the Eternity PhenylHexyl offers minimum bleed for LC/MS applications.
This fully wettable phase offers greater flexibility in developing orthogonal methods for challenging separations. It is an excellent choice to try when a C18 phase fails to provide an adequate separation.
This folder gives an overview of how you benefit. To learn more, visit www.kromasil.com or contact us directly!
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Mar 05 2024 Guangzhou, China
Apr 09 2024 Munich, Germany
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 28 2024 Montreal, Quebec, Canada